Q08DB4
Gene name |
CPNE1 |
Protein name |
Copine-1 |
Names |
Copine I |
Species |
Bos taurus (Bovine) |
KEGG Pathway |
bta:615677 |
EC number |
|
Protein Class |
|
Descriptions
The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.
Autoinhibitory domains (AIDs)
Target domain |
|
Relief mechanism |
|
Assay |
cis-regPred |
Accessory elements
No accessory elements
Autoinhibited structure
Activated structure
1 structures for Q08DB4
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| AF-Q08DB4-F1 | Predicted | AlphaFoldDB |
78 variants for Q08DB4
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs436498095 | 2 | A>P | No | EVA | |
| rs474371401 | 3 | H>N | No | EVA | |
| rs454324547 | 3 | H>P | No | EVA | |
| rs434236763 | 4 | C>W | No | EVA | |
| rs451958474 | 5 | V>G | No | EVA | |
| rs465668204 | 5 | V>L | No | EVA | |
| rs465668204 | 5 | V>M | No | EVA | |
| rs437577222 | 6 | T>P | No | EVA | |
| rs468820929 | 6 | T>S | No | EVA | |
| rs448868412 | 7 | L>M | No | EVA | |
| rs480122274 | 9 | Q>R | No | EVA | |
| rs466560490 | 15 | D>A | No | EVA | |
| rs1115267027 | 22 | I>V | No | EVA | |
| rs446622829 | 31 | V>G | No | EVA | |
| rs444327634 | 39 | G>C | No | EVA | |
| rs451053854 | 40 | N>I | No | EVA | |
| rs479993807 | 94 | L>I | No | EVA | |
| rs719638905 | 124 | R>Q | No | EVA | |
| rs474305904 | 132 | Q>* | No | EVA | |
| rs454188181 | 139 | V>E | No | EVA | |
| rs721650922 | 144 | V>L | No | EVA | |
| rs440586622 | 152 | K>E | No | EVA | |
| rs442293635 | 153 | D>G | No | EVA | |
| rs473009204 | 155 | L>V | No | EVA | |
| rs432831213 | 175 | A>T | No | EVA | |
| rs470662266 | 175 | A>V | No | EVA | |
| rs452407379 | 228 | H>L | No | EVA | |
| rs876085239 | 233 | Q>K | No | EVA | |
| rs876021876 | 233 | Q>L | No | EVA | |
| rs876358406 | 234 | L>M | No | EVA | |
| rs876290639 | 234 | L>P | No | EVA | |
| rs109308606 | 332 | S>A | No | EVA | |
| rs443302029 | 333 | D>G | No | EVA | |
| rs474686934 | 335 | L>Q | No | EVA | |
| rs440971345 | 338 | A>S | No | EVA | |
| rs472464257 | 339 | F>C | No | EVA | |
| rs452278155 | 344 | Q>E | No | EVA | |
| rs432277112 | 345 | V>L | No | EVA | |
| rs464347265 | 346 | P>H | No | EVA | |
| rs43711945 | 374 | D>N | No | EVA | |
| rs470738638 | 375 | A>P | No | EVA | |
| rs525776685 | 386 | F>Y | No | EVA | |
| rs1114386813 | 407 | N>D | No | EVA | |
| rs457140022 | 407 | N>S | No | EVA | |
| rs437032189 | 410 | N>T | No | EVA | |
| rs467008645 | 413 | Q>P | No | EVA | |
| rs446854999 | 420 | L>M | No | EVA | |
| rs478118495 | 423 | G>C | No | EVA | |
| rs464534529 | 425 | V>G | No | EVA | |
| rs450994671 | 436 | V>L | No | EVA | |
| rs442322976 | 438 | A>D | No | EVA | |
| rs462409199 | 438 | A>T | No | EVA | |
| rs479427558 | 440 | Y>F | No | EVA | |
| rs43711946 | 448 | V>L | No | EVA | |
| rs449170839 | 456 | E>K | No | EVA | |
| rs435704987 | 460 | Q>* | No | EVA | |
| rs714442375 | 464 | D>N | No | EVA | |
| rs439288025 | 465 | G>A | No | EVA | |
| rs457078288 | 467 | P>A | No | EVA | |
| rs474838925 | 472 | S>A | No | EVA | |
| rs473345680 | 473 | G>A | No | EVA | |
| rs434680838 | 473 | G>W | No | EVA | |
| rs453175801 | 476 | A>G | No | EVA | |
| rs464471199 | 477 | A>P | No | EVA | |
| rs464471199 | 477 | A>S | No | EVA | |
| rs468824344 | 479 | D>G | No | EVA | |
| rs448636138 | 481 | V>L | No | EVA | |
| rs445663215 | 487 | R>L | No | EVA | |
| rs460041906 | 487 | R>W | No | EVA | |
| rs477030407 | 488 | R>L | No | EVA | |
| rs463412851 | 489 | F>S | No | EVA | |
| rs434963129 | 507 | T>K | No | EVA | |
| rs466386173 | 511 | S>C | No | EVA | |
| rs452778159 | 513 | F>L | No | EVA | |
| rs449661434 | 518 | W>G | No | EVA | |
| rs481106671 | 520 | P>R | No | EVA | |
| rs467475031 | 530 | G>D | No | EVA | |
| rs447310627 | 531 | P>R | No | EVA |
No associated diseases with Q08DB4
5 regional properties for Q08DB4
| Type | Name | Position | InterPro Accession |
|---|---|---|---|
| domain | C2 domain | 1 - 114 | IPR000008-1 |
| domain | C2 domain | 123 - 245 | IPR000008-2 |
| domain | von Willebrand factor, type A | 283 - 485 | IPR002035 |
| domain | Copine, C-terminal | 251 - 518 | IPR010734 |
| domain | Copine, C2B domain | 138 - 245 | IPR037768 |
5 GO annotations of cellular component
| Name | Definition |
|---|---|
| aggresome | An inclusion body formed by dynein-dependent retrograde transport of an aggregated protein on microtubules. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| nuclear membrane | Either of the lipid bilayers that surround the nucleus and form the nuclear envelope; excludes the intermembrane space. |
| nucleoplasm | That part of the nuclear content other than the chromosomes or the nucleolus. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
6 GO annotations of molecular function
| Name | Definition |
|---|---|
| calcium ion binding | Binding to a calcium ion (Ca2+). |
| calcium-dependent phospholipid binding | Binding to a phospholipid, a class of lipids containing phosphoric acid as a mono- or diester, in the presence of calcium. |
| endopeptidase activity | Catalysis of the hydrolysis of internal, alpha-peptide bonds in a polypeptide chain. |
| identical protein binding | Binding to an identical protein or proteins. |
| NF-kappaB binding | Binding to NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters. |
| phosphatidylserine binding | Binding to phosphatidylserine, a class of glycophospholipids in which a phosphatidyl group is esterified to the hydroxyl group of L-serine. |
10 GO annotations of biological process
| Name | Definition |
|---|---|
| cellular response to calcium ion | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a calcium ion stimulus. |
| negative regulation of DNA binding | Any process that stops or reduces the frequency, rate or extent of DNA binding. DNA binding is any process in which a gene product interacts selectively with DNA (deoxyribonucleic acid). |
| negative regulation of gene expression | Any process that decreases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| negative regulation of NIK/NF-kappaB signaling | Any process that stops, prevents or reduces the frequency, rate or extent of NIK/NF-kappaB signaling. |
| neuron projection extension | Long distance growth of a single neuron projection involved in cellular development. A neuron projection is a prolongation or process extending from a nerve cell, e.g. an axon or dendrite. |
| positive regulation of neuron differentiation | Any process that activates or increases the frequency, rate or extent of neuron differentiation. |
| positive regulation of protein kinase B signaling | Any process that activates or increases the frequency, rate or extent of protein kinase B signaling, a series of reactions mediated by the intracellular serine/threonine kinase protein kinase B. |
| positive regulation of tumor necrosis factor-mediated signaling pathway | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor-mediated signaling pathway. |
| proteolysis | The hydrolysis of proteins into smaller polypeptides and/or amino acids by cleavage of their peptide bonds. |
| regulation of I-kappaB kinase/NF-kappaB signaling | Any process that modulates I-kappaB kinase/NF-kappaB signaling. |
5 homologous proteins in AiPD
| 10 | 20 | 30 | 40 | 50 | 60 |
| MAHCVTLVQL | SVSCDHLIDK | DIGSKSDPLC | VLLQDVGGGN | WTELGRTERV | QNCSSPEFSK |
| 70 | 80 | 90 | 100 | 110 | 120 |
| TLQLEYHFET | VQKLRFGIYD | IDNKTPELGD | DDFLGGAECS | LGQIVSSRML | TLPLMLKPGK |
| 130 | 140 | 150 | 160 | 170 | 180 |
| PAGRGTITVS | AQELKDNRVV | TMEVEARNLD | KKDFLGKSDP | FLEFFRQGDG | KWHLAYRSEV |
| 190 | 200 | 210 | 220 | 230 | 240 |
| IKNNLNPTWK | RFSVPLQHFC | GGDASTPIQV | RCSDYDSDGS | HDLIGTFHTS | LAQLQAAPAE |
| 250 | 260 | 270 | 280 | 290 | 300 |
| FECIHPEKQQ | KKKSYKNSGT | ICVKMCQVET | EHSFLDYVMG | GCQINFTVGV | DFTGSNGDPS |
| 310 | 320 | 330 | 340 | 350 | 360 |
| SPDSLHYLSP | TGVNEYLTAL | WSVGSVVQDY | DSDKLFPAFG | FGAQVPPDWQ | VSHEFALNFN |
| 370 | 380 | 390 | 400 | 410 | 420 |
| PSNPFCAGIQ | GIVDAYRQAL | PQVRLFGPTN | FAPIINHVAR | FAAQAANQRN | ASQYFVLLLL |
| 430 | 440 | 450 | 460 | 470 | 480 |
| TDGAVTDVEA | TREAVVRASY | LPMSVIIVGV | GCADFEAMEQ | LDADGGPLHT | RSGEAAARDI |
| 490 | 500 | 510 | 520 | 530 | |
| VQFVPYRRFQ | NAPREALAQT | VLAEVPTQLV | SYFRAQGWAP | FKPPPPAAKG | PAQAPQA |